Heterogeneity of penetrance in familial amyloid polyneuropathy, ATTR Val30Met, in the Swedish population

References

• Plante-Bordeneuve V, Said G. Transthyretin related familial amyloid polyneuropathy. Curr Opin Neurol 2000; 13: 569–573
   PubMed Web of Science ®Google Scholar
• Suhr O, Danielsson A, Holmgren G, Steen L. Malnutrition and gastrointestinal dysfunction as prognostic factors for survival in familial amyloidotic polyneuropathy. J Intern Med 1994; 235: 479–485
   PubMed Web of Science ®Google Scholar
• Suhr O B, Holmgren G, Steen L, Wikstrom L, Norden G, Friman S, Duraj F F, Groth C G, Ericzon B G. Liver transplantation in familial amyloidotic polyneuropathy. Follow-up of the first 20 Swedish patients. Transplantation 1995; 60: 933–938
   PubMed Web of Science ®Google Scholar
• Adams D, Samuel D, Goulon-Goeau C, Nakazato M, Costa P M, Feray C, Plante V, Ducot B, Ichai P, Lacroix C, Metral S, Bismuth H, Said G. The course and prognostic factors of familial amyloid polyneuropathy after liver transplantation. Brain 2000; 123: 1495–1504
   PubMed Web of Science ®Google Scholar
• Andrade C. A peculiar form of peripheral neuropathy. Familiar atypical generalized amyloidosis with special involvement of the peripheral nerves. Brain 1952; 75: 408–427
   PubMed Web of Science ®Google Scholar
• Reilly M M, Adams D, Booth D R, Davis M B, Said G, Laubriat-Bianchin M, Pepys M B, Thomas P K, Harding A E. Transthyretin gene analysis in European patients with suspected familial amyloid polyneuropathy. Brain 1995; 118: 849–856
   PubMed Web of Science ®Google Scholar
• Ikeda S, Nakazato M, Ando Y, Sobue G. Familial transthyretin-type amyloid polyneuropathy in Japan: clinical and genetic heterogeneity. Neurology 2002; 58: 1001–1007
   PubMed Web of Science ®Google Scholar
• Sousa A, Andersson R, Drugge U, Holmgren G, Sandgren O. Familial amyloidotic polyneuropathy in Sweden: geographical distribution, age of onset, and prevalence. Hum Hered 1993; 43: 288–294
   PubMed Web of Science ®Google Scholar
• Saraiva M J. Transthyretin mutations in hyperthyroxinemia and amyloid diseases. Hum Mutat 2001; 17: 493–503
   PubMed Web of Science ®Google Scholar
• Sousa A, Coelho T, Barros J, Sequeiros J. Genetic epidemiology of familial amyloidotic polyneuropathy (FAP)-type I in Povoa do Varzim and Vila do Conde (north of Portugal). Am J Med Genet 1995; 60: 512–521
   PubMed Web of Science ®Google Scholar
• Holmgren G, Costa P M, Andersson C, Asplund K, Steen L, Beckman L, Nylander P O, Teixeira A, Saraiva M J, Costa P P. Geographical distribution of TTR met30 carriers in northern Sweden: discrepancy between carrier frequency and prevalence rate. J Med Genet 1994; 31: 351–354
   PubMed Web of Science ®Google Scholar
• Drugge U, Andersson R, Chizari F, Danielsson M, Holmgren G, Sandgren O, Sousa A. Familial amyloidotic polyneuropathy in Sweden: a pedigree analysis. J Med Genet 1993; 30: 388–392
   PubMed Web of Science ®Google Scholar
• Plante-Bordeneuve V, Carayol J, Ferreira A, Adams D, Clerget-Darpoux F, Misrahi M, Said G, Bonaiti-Pellie C. Genetic study of transthyretin amyloid neuropathies: carrier risks among French and Portuguese families. J Med Genet 2003; 40: e120
   PubMed Web of Science ®Google Scholar
• Holmgren G, Bergstrom S, Drugge U, Lundgren E, Nording-Sikstrom C, Sandgren O, Steen L. Homozygosity for the transthyretin-Met30-gene in seven individuals with familial amyloidosis with polyneuropathy detected by restriction enzyme analysis of amplified genomic DNA sequences. Clin Genet 1992; 41: 39–41
   PubMed Web of Science ®Google Scholar
• Fuchs U, Zittermann A, Suhr O, Holmgren G, Tenderich G, Minami K, Koerfer R. Heart transplantation in a patient with senile cardiomyopathy. Am J Transplant 2005; 5: 1159–1162
   PubMed Web of Science ®Google Scholar
• Sposto R. Cure model analysis in cancer: an application to data from the Children's Cancer Group. Stat Med 2002; 21: 293–312
   PubMed Web of Science ®Google Scholar
• Ando Y, Nyhlin N, Suhr O, Holmgren G, Uchida K, El Sahly M, Yamashita T, Terasaki H, Nakamura M, Uchino M, Ando M. Oxidative stress is found in amyloid deposits in systemic amyloidosis. Biochem Biophys Res Commun 1997; 232: 497–502
   PubMed Web of Science ®Google Scholar
• Nyhlin N, Ando Y, Nagai R, Suhr O, El Sahly M, Terazaki H, Yamashita T, Ando M, Horiuchi S. Advanced glycation end product in familial amyloidotic polyneuropathy (FAP). J Intern Med 2000; 247: 485–492
   PubMed Web of Science ®Google Scholar
• Hardell L, Holmgren G, Steen L, Fredrikson M, Axelson O. Occupational and other risk factors for clinically overt familial amyloid polyneuropathy. Epidemiology 1995; 6: 598–601
   PubMed Web of Science ®Google Scholar
• Holmgren G, Wikstrom L, Lundgren H E, Suhr O B. Discordant penetrance of the trait for familial amyloidotic polyneuropathy in two pairs of monozygotic twins. J Intern Med 2004; 256: 453–456
   PubMed Web of Science ®Google Scholar
• Yamamoto K, Ikeda S, Hanyu N, Takeda S, Yanagisawa N. A pedigree analysis with minimised ascertainment bias shows anticipation in Met30-transthyretin related familial amyloid polyneuropathy. J Med Genet 1998; 35: 23–30
   PubMed Web of Science ®Google Scholar